BRPI0512288B8 - uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno - Google Patents

uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno

Info

Publication number
BRPI0512288B8
BRPI0512288B8 BRPI0512288A BRPI0512288A BRPI0512288B8 BR PI0512288 B8 BRPI0512288 B8 BR PI0512288B8 BR PI0512288 A BRPI0512288 A BR PI0512288A BR PI0512288 A BRPI0512288 A BR PI0512288A BR PI0512288 B8 BRPI0512288 B8 BR PI0512288B8
Authority
BR
Brazil
Prior art keywords
triterpene
oilgel
producing
weight
highly dispersed
Prior art date
Application number
BRPI0512288A
Other languages
English (en)
Portuguese (pt)
Inventor
Scheffler Armin
Original Assignee
Birken Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0512288(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken Gmbh filed Critical Birken Gmbh
Publication of BRPI0512288A publication Critical patent/BRPI0512288A/pt
Publication of BRPI0512288B1 publication Critical patent/BRPI0512288B1/pt
Publication of BRPI0512288B8 publication Critical patent/BRPI0512288B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Volume Flow (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0512288A 2004-06-22 2005-06-21 uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno BRPI0512288B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004030044.5 2004-06-22
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
PCT/EP2005/006710 WO2005123037A1 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels

Publications (3)

Publication Number Publication Date
BRPI0512288A BRPI0512288A (pt) 2008-03-25
BRPI0512288B1 BRPI0512288B1 (pt) 2019-05-21
BRPI0512288B8 true BRPI0512288B8 (pt) 2021-05-25

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512288A BRPI0512288B8 (pt) 2004-06-22 2005-06-21 uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno

Country Status (31)

Country Link
US (2) US8536380B2 (OSRAM)
EP (1) EP1758555B2 (OSRAM)
JP (1) JP4468987B2 (OSRAM)
KR (1) KR101162991B1 (OSRAM)
CN (1) CN1972668B (OSRAM)
AT (1) ATE423546T1 (OSRAM)
AU (1) AU2005253732C1 (OSRAM)
BE (1) BE2016C035I2 (OSRAM)
BR (1) BRPI0512288B8 (OSRAM)
CA (1) CA2571606C (OSRAM)
CY (2) CY1109066T1 (OSRAM)
DE (2) DE102004030044A1 (OSRAM)
DK (1) DK1758555T4 (OSRAM)
ES (1) ES2323082T5 (OSRAM)
FR (1) FR16C1003I2 (OSRAM)
HU (1) HUS1600032I1 (OSRAM)
IL (1) IL180057A (OSRAM)
LT (1) LTC1758555I2 (OSRAM)
LU (1) LU93142I2 (OSRAM)
MX (1) MXPA06015233A (OSRAM)
NL (1) NL300823I2 (OSRAM)
NO (2) NO336747B1 (OSRAM)
NZ (1) NZ552280A (OSRAM)
PL (1) PL1758555T5 (OSRAM)
PT (1) PT1758555E (OSRAM)
RS (1) RS50832B2 (OSRAM)
RU (1) RU2430717C2 (OSRAM)
SI (1) SI1758555T1 (OSRAM)
UA (1) UA88308C2 (OSRAM)
WO (1) WO2005123037A1 (OSRAM)
ZA (1) ZA200610304B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (de) * 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
ES2537151T3 (es) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes
EP2363108B1 (de) 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Schaumformulierungen enthaltend mindestens ein Triterpenoid
EP3597206A1 (en) 2011-06-21 2020-01-22 BVW Holding AG Medical device comprising boswellic acid
CA3022218C (en) * 2016-05-12 2023-05-09 Rudjer Boskovic Institute Low molecular weight organic gelators of vegetable oil
US20190183797A1 (en) * 2016-07-18 2019-06-20 Rolf Daniels Betulin-containing water-in-oil foams and compositions thereof
CN110402402B (zh) * 2017-03-10 2022-01-11 科腾聚合物美国有限责任公司 易熔的油凝胶组合物和其制备及使用方法
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
CN111556757A (zh) 2017-10-31 2020-08-18 西方溶瘤细胞有限公司 用于全身递送的平台溶瘤载体
SG11202003668YA (en) 2018-01-04 2020-05-28 Amryt Res Limited Betulin-containing birch bark extracts and their formulation
CN113164384A (zh) 2018-10-26 2021-07-23 维拉莫有限公司 黏膜粘附性凝胶组合物
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
KR20230110545A (ko) 2020-11-19 2023-07-24 칼리버 임뮤노쎄라퓨틱스, 인크. 종양 미세환경 재형성에 의한 종양용해 면역요법
MX2023012608A (es) 2021-04-30 2023-11-03 Kalivir Immunotherapeutics Inc Virus oncoliticos para la expresion modificada del mhc.
DE102024116319B3 (de) 2024-06-11 2025-10-30 Fuchs SE Schmierfett-Zusammensetzungen enthaltend pentacyclische Triterpene als Co-Verdicker, deren Verwendung und Verfahren zu deren Herstellung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
HK1046502B (en) 1999-07-09 2003-09-19 Astion Development Aps Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
DE60102402T2 (de) * 2000-02-10 2005-03-10 Loders Croklaan B.V. Fettmischungen mit Kristallmodifikatoren
EP1267900B1 (de) * 2000-03-28 2004-04-21 Birken Gmbh Emulsion enthaltend einen triterpen-haltigen pflanzenextrakt, verfahren zur herstellung der emulsion sowie zur gewinnung des pflanzenextraktes
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
WO2002026761A1 (en) * 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
US6689767B2 (en) * 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) * 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
ZA200610304B (en) 2007-11-28
NO336747B1 (no) 2015-10-26
JP4468987B2 (ja) 2010-05-26
EP1758555A1 (de) 2007-03-07
AU2005253732B2 (en) 2009-07-16
RS50832B2 (sr) 2018-09-28
CN1972668A (zh) 2007-05-30
FR16C1003I1 (OSRAM) 2016-08-26
DK1758555T4 (da) 2011-12-19
BRPI0512288A (pt) 2008-03-25
LU93142I2 (fr) 2016-09-06
AU2005253732A1 (en) 2005-12-29
DE102004030044A1 (de) 2006-01-12
ATE423546T1 (de) 2009-03-15
NO2016012I2 (no) 2016-07-07
IL180057A0 (en) 2007-05-15
JP2008503530A (ja) 2008-02-07
CY2016025I2 (el) 2016-10-05
ES2323082T5 (es) 2012-01-05
US8828444B2 (en) 2014-09-09
US8536380B2 (en) 2013-09-17
BE2016C035I2 (OSRAM) 2024-10-08
EP1758555B2 (de) 2011-09-07
NO20070390L (no) 2007-03-16
LU93142I9 (OSRAM) 2024-11-04
KR101162991B1 (ko) 2012-07-10
US20140050790A1 (en) 2014-02-20
UA88308C2 (ru) 2009-10-12
EP1758555B1 (de) 2009-02-25
LTC1758555I2 (lt) 2017-11-10
US20070299285A1 (en) 2007-12-27
CA2571606A1 (en) 2005-12-29
CY2016025I1 (el) 2016-10-05
PL1758555T3 (pl) 2009-07-31
IL180057A (en) 2013-11-28
KR20070046821A (ko) 2007-05-03
CA2571606C (en) 2011-07-19
DE502005006701D1 (de) 2009-04-09
NZ552280A (en) 2010-10-29
DK1758555T3 (da) 2009-06-22
CN1972668B (zh) 2013-01-09
SI1758555T2 (sl) 2009-08-31
FR16C1003I2 (fr) 2018-01-19
BRPI0512288B1 (pt) 2019-05-21
SI1758555T1 (sl) 2009-08-31
CY1109066T1 (el) 2014-07-02
MXPA06015233A (es) 2007-12-12
RS50832B (sr) 2010-08-31
WO2005123037A1 (de) 2005-12-29
RU2430717C2 (ru) 2011-10-10
NL300823I2 (nl) 2017-06-22
HUS1600032I1 (hu) 2016-08-29
NO2016012I1 (no) 2016-07-07
PL1758555T5 (pl) 2011-12-30
AU2005253732C1 (en) 2010-01-21
PT1758555E (pt) 2009-04-24
ES2323082T3 (es) 2009-07-06
RU2007102084A (ru) 2008-07-27

Similar Documents

Publication Publication Date Title
BRPI0512288B8 (pt) uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno
BRPI0921192A2 (pt) Compósito para almofada resiliente e processo para produzir o mesmo
AR060241A1 (es) Composiciones y metodos de uso para anticuerpos de c-met
DE602006006082D1 (de) Plattenstruktur
ES2603070T3 (es) Aglutinante de aluminosilicato activado por álcali que contiene perlas de vidrio
BR112014030020A2 (pt) aparelho para montagem de seções de pá
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
AR065368A1 (es) Anticuerpos para moleculas de ige
BRPI0810130A8 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida
BR112023018344A2 (pt) Composições de cimento, e métodos das mesmas
BR112015023209A8 (pt) novos medicamentos compreendendo uma composição de anticorpo enriquecida com uma carga principal de isoforma
BR112017022878A2 (pt) composição, preparação simbiótica, processo para produzir uma composição, e, uso de uma arabinoxilanase
BRPI0411471A (pt) método para produzir um não-trançado fibroso e não-trançado fibroso
MX2023009882A (es) Anticuerpos anti-muc1-c y estructuras car-t.
BRPI0517824A (pt) processo para a sìntese de zeólita beta com dietilenotriamina
BRPI0401917A (pt) Material em chapa aglutinado com elastÈmero e processo para sua produção
EA200800148A1 (ru) Применение фуллерена с60 в качестве стабилизатора масел
NO20064237L (no) Furosemide modulatorer for HM74
BRPI0517669A (pt) método para gerar uma imagem composta
BR112012018427A2 (pt) uso de composto, e, método para aumentar o ph de uma suspensão aquosa
CR8537A (es) Moduladores de HM74 de Oxidecahidronaftaleno
ES2329218A1 (es) Neoglicolipidos, sus agregados con nanotubos de carbono, procedimiento de obtencion y aplicaciones
BRPI0805607A2 (pt) suporte para unidades de controle, em especial para unidades de controle de veìculo e feixes de cabo
BRPI0703888A2 (pt) uso de uma matriz ternÁria como adaptador de informaÇÕes biolàgicas moleculares, e, mÉtodo de consulta e visualizaÇço de informaÇÕes biàlogicas moleculares armazenadas em pelo menos uma base de dados

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF